Femasys Inc. – NASDAQ:FEMY

Femasys stock price today

$0.695
-0.43
-38.5%
Financial Health
0
1
2
3
4
5
6
7
8
9

Femasys stock price monthly change

-0.88%
month

Femasys stock price quarterly change

-0.88%
quarter

Femasys stock price yearly change

+18.95%
year

Femasys key metrics

Market Cap
24.50M
Enterprise value
N/A
P/E
-1.14
EV/Sales
-1.45
EV/EBITDA
0.17
Price/Sales
5.40
Price/Book
0.64
PEG ratio
0.02
EPS
-0.85
Revenue
1.04M
EBITDA
-13.87M
Income
-14.90M
Revenue Q/Q
-7.77%
Revenue Y/Y
-11.00%
Profit margin
-923.74%
Oper. margin
-936.4%
Gross margin
63.57%
EBIT margin
-936.4%
EBITDA margin
-1322.16%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Femasys stock price history

Femasys stock forecast

Femasys financial statements

Femasys Inc. (NASDAQ:FEMY): Profit margin
Jun 2023 320.51K -2.89M -902.77%
Sep 2023 244.36K -3.99M -1635.66%
Dec 2023 213.11K -4.41M -2069.56%
Mar 2024 271.14K -3.59M -1327.55%
Femasys Inc. (NASDAQ:FEMY): Analyst Estimates
Sep 2025 4.46M 0
Oct 2025 3.61M -2.83M -78.23%
Dec 2025 4.63M 0
Dec 2025 4.03M -1.95M -48.53%
  • Analysts Price target

  • Financials & Ratios estimates

Femasys Inc. (NASDAQ:FEMY): Earnings per share (EPS)
2023-11-14 -0.25 -0.26
2024-03-28 -0.19 -0.19
2024-05-09 -0.22 -0.17
Femasys Inc. (NASDAQ:FEMY): Debt to assets
Jun 2023 14313961 1.43M 10.04%
Sep 2023 14853537 4.40M 29.69%
Dec 2023 27755825 9.40M 33.88%
Mar 2024 24370960 8.76M 35.96%
Femasys Inc. (NASDAQ:FEMY): Cash Flow
Jun 2023 -2.74M -62.94K 3.34M
Sep 2023 -2.85M -27.16K 870.32K
Dec 2023 -3.03M -44.89K 16.10M
Mar 2024 -4.56M -90.16K 778.17K

Femasys alternative data

Femasys Inc. (NASDAQ:FEMY): Employee count
Aug 2023 34
Sep 2023 34
Oct 2023 34
Nov 2023 34
Dec 2023 34
Jan 2024 34
Feb 2024 34
Mar 2024 34
Apr 2024 34
May 2024 32
Jun 2024 32
Jul 2024 32

Femasys other data

7.31% -1.37%
of FEMY is owned by hedge funds
863.78K -161.18K
shares is hold by hedge funds

Femasys Inc. (NASDAQ:FEMY): Insider trades (number of shares)
Period Buy Sel
Jun 2021 200500 0
Transaction Date Insider Security Shares Price per share Total value Source
Purchase
DYETT JOHN director, 10 percent owner
Common Stock 1,000 $9.95 $9,950
Purchase
LARSEN CHARLES director
Common Stock 7,000 $13 $91,000
Purchase
DYETT JOHN director, 10 percent owner
Common Stock 40,000 $13 $520,000
Purchase
UZIALKO EDWARD R director
Common Stock 100,000 $13 $1,300,000
Purchase
ADAMS JOHN Q JR director
Common Stock 40,000 $13 $520,000
Purchase
DYETT JOHN director, 10 percent owner
Common Stock 10,000 $12.88 $128,800
Purchase
DYETT JOHN director, 10 percent owner
Common Stock 2,500 $13.18 $32,950
Tuesday, 26 November 2024
globenewswire.com
Tuesday, 12 November 2024
zacks.com
globenewswire.com
Friday, 1 November 2024
globenewswire.com
Thursday, 10 October 2024
globenewswire.com
Wednesday, 2 October 2024
globenewswire.com
Wednesday, 18 September 2024
globenewswire.com
Wednesday, 11 September 2024
globenewswire.com
Tuesday, 10 September 2024
zacks.com
Monday, 9 September 2024
globenewswire.com
Thursday, 5 September 2024
globenewswire.com
Tuesday, 3 September 2024
zacks.com
globenewswire.com
Thursday, 29 August 2024
globenewswire.com
Tuesday, 27 August 2024
globenewswire.com
Thursday, 8 August 2024
zacks.com
globenewswire.com
Thursday, 27 June 2024
globenewswire.com
Friday, 17 May 2024
globenewswire.com
Thursday, 16 May 2024
globenewswire.com
Thursday, 9 May 2024
Zacks Investment Research
Thursday, 2 May 2024
Zacks Investment Research
Thursday, 5 October 2023
MarketBeat
Monday, 2 October 2023
InvestorPlace
Tuesday, 26 September 2023
InvestorPlace
Thursday, 27 July 2023
InvestorPlace
Monday, 3 July 2023
Zacks Investment Research
Monday, 21 November 2022
GlobeNewsWire
  • What's the price of Femasys stock today?

    One share of Femasys stock can currently be purchased for approximately $0.7.

  • When is Femasys's next earnings date?

    Unfortunately, Femasys's (FEMY) next earnings date is currently unknown.

  • Does Femasys pay dividends?

    No, Femasys does not pay dividends.

  • How much money does Femasys make?

    Femasys has a market capitalization of 24.50M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 11.13% to 1.07M US dollars. Femasys made a loss 14.25M US dollars in net income (profit) last year or -$0.17 on an earnings per share basis.

  • What is Femasys's stock symbol?

    Femasys Inc. is traded on the NASDAQ under the ticker symbol "FEMY".

  • What is Femasys's primary industry?

    Company operates in the Healthcare sector and Medical - Instruments & Supplies industry.

  • How do i buy shares of Femasys?

    Shares of Femasys can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Femasys have?

    As Jul 2024, Femasys employs 32 workers, which is 6% less then previous quarter.

  • When Femasys went public?

    Femasys Inc. is publicly traded company for more then 4 years since IPO on 18 Jun 2021.

  • What is Femasys's official website?

    The official website for Femasys is femasys.com.

  • Where are Femasys's headquarters?

    Femasys is headquartered at 3950 Johns Creek Court, Suwanee, GA.

  • How can i contact Femasys?

    Femasys's mailing address is 3950 Johns Creek Court, Suwanee, GA and company can be reached via phone at +7 705003910.

Femasys company profile:

Femasys Inc.

femasys.com
Exchange:

NASDAQ

Full time employees:

32

Industry:

Medical - Instruments & Supplies

Sector:

Healthcare

Femasys Inc., a biomedical company, focuses on women's healthcare market in the United States. The company develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; FemCerv, a biopsy device for endocervical curettage; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. It also commercializes FemVue saline-air device in the United States, Europe, Canada, Japan, and internationally. The company offers its infertility products to obstetrics-gynecological physicians, related healthcare professionals, women's healthcare provider organizations, and reproductive endocrinologists. In addition, it provides non-surgical product technologies. Femasys Inc. was incorporated in 2004 and is based in Suwanee, Georgia.

3950 Johns Creek Court
Suwanee, GA 30024

CIK: 0001339005
ISIN: US31447E1055
CUSIP: 31447E105